Evaluating Effectiveness and Safety of Flumatinib for Chronic Phase Chronic Myeloid Leukemia in (CML-CP) without Optimal Response (Warning, Failure) to Imatinib or/and Dasatinib
Resource Type
Article
Authors
Weiming, Li ; Zhang, Yanli ; Wu, Zhiwei ; Wen, Qin ; Leng, Qing ; Wu, Shuting ; Wang, Xiaodong ; Chen, Shiming ; Yuan, Guolin ; Qian, Sixuan ; Chen, Suning ; Jiang, Daozi ; Diao, Lianjun ; Xi, Zhenfang ; Wu, Hui ; Sun, Hui ; Yang, Lijie ; Wang, Hongjuan ; Zhang, Xuefang ; Xu, Yanli ; Zhao, Xielan ; Xu, Na ; Meng, Li ; Zhu, Zunmin ; Zhao, Youfang ; Su, Meifang ; Yang, Zhuangzhi ; Liu, Chuancai ; Han, Danlei ; Hu, Yu
Source
Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p3171-3171, 1p
Subject
Language
ISSN
00064971; 15280020